湿性老年性黄斑变性的疾病负担研究

发布时间：2018-12-07 20:44

【摘要】：目的:研究国内湿性老年性黄斑变性的疾病负担。方法:采用多中心、回顾加现况调查设计。北京、成都、广州和上海作为样本城市,各个城市分别选取若干家样本医院。按照入选和剔除标准筛选病例,分为光动力疗法、光凝、手术、联合和支持5个组,对直接成本、间接成本和疾病负担进行研究。统计软件用SPSS 17.0。结果:获得合格病例417例,男性占51.32%,女性占48.68%。每眼年的疾病负担为32 882元。每眼全病程的疾病负担为230 172元。在疾病负担中直接医疗成本所占的比例并不高(26.35%),而间接成本所占的比例较高(68.58%)。结论:湿性老年性黄斑变性的疾病负担已经比较高,应当引起利益相关者的重视。新的诊疗方法尽管会增加直接医疗成本,但有可能会降低疾病负担,这为新技术的应用展示了空间。推行诊疗规范既有利于对患者的规范治疗又有利于对直接医疗成本的管理。对年轻患者的优先防治有利于社会总疾病负担的降低。
[Abstract]:Objective: to study the disease burden of wet age-related macular degeneration in China. Methods: a multi-center, retrospective and current survey design was used. Beijing, Chengdu, Guangzhou and Shanghai as sample cities, each city selected a number of sample hospitals. According to the selection and elimination criteria, the patients were divided into five groups: photodynamic therapy, photocoagulation, surgery, combination and support. The direct cost, indirect cost and disease burden were studied. SPSS 17.0. Results: 417 eligible cases were obtained, male 51.32 and female 48.68. The disease burden is 32,882 yuan per eye year. The disease burden per eye was 230,172 yuan. The proportion of direct medical cost in disease burden was not high (26.35%), but the proportion of indirect cost was higher (68.58%). Conclusion: the disease burden of wettable age-related macular degeneration is high and should be paid more attention to by stakeholders. New methods of diagnosis and treatment, while increasing the cost of direct medical care, may reduce the burden of disease, showing space for the application of new technologies. The implementation of diagnostic and treatment norms is not only conducive to the standardized treatment of patients, but also to the management of direct medical costs. The priority of prevention and treatment for young patients is conducive to the reduction of total social disease burden.
【作者单位】：上海应用技术学院人文学院劳动与社会保障教研室;复旦大学公共卫生学院卫生经济教研室;北京诺华制药有限公司;
【分类号】：R774.5

【相似文献】